We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

87 hedge funds and large institutions have $510M invested in Aratana Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

85% more capital invested

Capital invested by funds: $276M → $510M (+$234M)

80% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 20

6% more funds holding

Funds holding: 82 → 87 (+5)

Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
36
Reduced
20
Closed
8
Calls
$188K
Puts
–
Net Calls
+$188K
Net Calls Change
+$193K

Top Buyers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
+$6.69M
2
BFA
BlackRock Fund Advisors
California
+$6.6M
3
Lazard Asset Management
Lazard Asset Management
New York
+$6.55M
4
VAM
Visium Asset Management
New York
+$2.74M
5
KCM
Kornitzer Capital Management
Kansas
+$2.07M

Top Sellers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
-$5.56M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.43M
3
JP Morgan Chase
JP Morgan Chase
New York
-$3.15M
4
UOC
UBS O'Connor
Illinois
-$2.72M
5
Barclays
Barclays
United Kingdom
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCMT
26
Highland Capital Management (Texas)
Texas
$3.79M -$5.56M -446,066 -68%
KCM
27
Kornitzer Capital Management
Kansas
$3.7M +$2.07M +166,000 +401%
WRF
28
Waddell & Reed Financial
Kansas
$3.56M -$2.5M -200,600 -50%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.49M +$790K +63,421 +48%
IHM
30
Iguana Healthcare Management
New York
$3.21M +$374K +30,000 +20%
GPGA
31
Grandeur Peak Global Advisors
Utah
$3.2M -$536K -43,050 -19%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$3.06M +$613K +49,210 +40%
TCIM
33
TIAA CREF Investment Management
New York
$2.66M +$444K +35,608 +31%
EI
34
EAM Investors
California
$2.64M +$1.85M +148,203 New
Morgan Stanley
35
Morgan Stanley
New York
$2.28M +$1.37M +109,862 +608%
DCM
36
Driehaus Capital Management
Illinois
$1.95M +$217K +17,384 +19%
Millennium Management
37
Millennium Management
New York
$1.81M -$1.09M -87,294 -46%
BIM
38
BlackRock Investment Management
Delaware
$1.47M +$4.06K +326 +0.4%
Alyeska Investment Group
39
Alyeska Investment Group
Illinois
$1.45M -$304K -24,396 -23%
WCM
40
Westend Capital Management
California
$1.34M +$937K +75,210 New
Ameriprise
41
Ameriprise
Minnesota
$1.18M +$824K +66,133 +165,333%
TCM
42
Tygh Capital Management
Oregon
$1.15M +$803K +64,410 New
WMSA
43
Weiss Multi-Strategy Advisers
New York
$1.07M +$374K +30,000 +100%
FLAM
44
First Light Asset Management
Minnesota
$1.03M +$54.8K +4,398 +8%
CS
45
Credit Suisse
Switzerland
$987K +$376K +30,210 +120%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$950K +$2.83K +227 +0.4%
RFC
47
Russell Frank Company
Washington
$908K +$639K +51,287 New
Charles Schwab
48
Charles Schwab
California
$818K – – –
TA
49
Teachers Advisors
New York
$816K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$790K -$58.8K -4,721 -10%
1
2
3 4

PETX Hedge Fund Activity: Q4 2014 in Review

87 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q4 2014, worth a combined $510M — up 85% from $276M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new PETX positions and 8 closed out — a net gain of 7 holders — while 36 added to existing stakes and 20 trimmed.

The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $6.69M. The largest seller was Highland Capital Management (Texas), cutting an estimated $5.56M.

  • 87 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q4 2014, up from 82 in Q3 2014.
  • Funds reported $510M of Aratana Therapeutics, Inc. stock for Q4 2014, up 85% quarter-over-quarter.
  • 15 funds opened new Aratana Therapeutics, Inc. positions in Q4 2014 and 8 closed out, a net change of +7 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q4 2014 was Columbus Circle Investors, an estimated $6.69M added.
  • The largest Aratana Therapeutics, Inc. seller in Q4 2014 was Highland Capital Management (Texas), an estimated $5.56M sold.

Based on aggregated 13F filings for Q4 2014.